Your session is about to expire
← Back to Search
Early Treatment for Retinopathy of Prematurity
Phase 2 & 3
Waitlist Available
Research Sponsored by National Eye Institute (NEI)
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Infants <1251 grams birthweight born at participating centers and/or examined by 42 days of life
Infants must have prethreshold retinopathy of prematurity (ROP) for the early treatment trial.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
Study Summary
This trial is testing whether earlier treatment of ROP will result in better visual outcomes than treating at the conventional threshold point.
Who is the study for?
The ETROP study is for premature infants born weighing less than 1251 grams and diagnosed with prethreshold retinopathy of prematurity (ROP). They must be examined by 42 days of life at participating centers to qualify.Check my eligibility
What is being tested?
This trial investigates whether treating ROP earlier than the usual time improves visual outcomes. Infants are selected based on specific criteria and receive treatment before reaching the conventional threshold for intervention.See study design
What are the potential side effects?
Since this summary does not provide details about specific interventions, side effects cannot be accurately described. Generally, treatments for ROP may include laser therapy or cryotherapy, which can have risks like bleeding or scarring.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
My baby was born weighing less than 1251 grams and was either born at or examined by a participating center within 42 days of life.
Select...
My infant has a severe eye condition due to premature birth.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 5 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
Treatment Details
Find a Location
Who is running the clinical trial?
National Eye Institute (NEI)Lead Sponsor
546 Previous Clinical Trials
1,401,928 Total Patients Enrolled
15 Trials studying Retinopathy of Prematurity
4,658 Patients Enrolled for Retinopathy of Prematurity
William V. Good, M.D.Study ChairSmith-Kettlewell Eye Research Institute
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- My baby was born weighing less than 1251 grams and was either born at or examined by a participating center within 42 days of life.My infant has a severe eye condition due to premature birth.
Research Study Groups:
This trial has the following groups:Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Can patients over the age of 30 sign up for this test?
"This trial is open to subjects that fall between 0-42 days old."
Answered by AI
Are you looking for volunteers for this experiment right now?
"This particular clinical trial is no longer looking for patients, as noted on clinicaltrials.gov. The study was created on October 1st, 2001 but was last updated on June 23rd, 2005. There are other trials, however, that are actively recruiting patients."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger